The bad news continues to mount for Johnson & Johnson’s (NYSE:JNJ) cardiac stent-making arm Cordis Corp., which received an FDA warning letter about a manufacturing facility in Puerto Rico.
Stent Wars
Boston Scientific launches Omega stent in Europe
Boston Scientific Corp.’s (NYSE:BSX) third-generation stent platform, the platinum-chromium Omega bare-metal stent, won CE Mark approval in the European Union.
Boston Scientific said it plans to make the device available "immediately" in the EU and other countries that recognize the mark. It’s the first of a trio of stents the Natick, Mass.-based medical device maker plans to launch on the platform, according to a press release.